Yüklüyor......
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis
Background: Dalfampridine extended release (ER) improves walking in people with multiple sclerosis (MS), as demonstrated by walking speed improvement. This exploratory study evaluated treatment effects of dalfampridine-ER on gait, balance, and walking through treatment withdrawal and reinitiation. M...
Kaydedildi:
| Yayımlandı: | Int J MS Care |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Consortium of Multiple Sclerosis Centers
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673920/ https://ncbi.nlm.nih.gov/pubmed/26664333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2014-036 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|